Abstract
One of the most exciting things about subcutaneous DMPA (DMPA-SC, or Sayana® Press* ) is its potential to empower women and adolescent girls and dramatically increase contraceptive access. This promise can only be fulfilled if enabling policies are in place. Many countries, however, have policy restrictions that hamper the provision of injectable contraceptives through key service delivery channels for DMPA-SC such as community-based distribution (CBD), private-sector provision, and self-injection.
